Insider trades › Procter & Gamble › Paul Gama
Paul Gama: Procter & Gamble stock transactions
Paul Gama (CEO- Health Care at Procter & Gamble) reported 4 transactions in PG stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Gama Paul.
$812Kopen-market sales (5,621 shares)
$0open-market purchases (0 shares)
2026-10-05most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Oct 5, 2026 | Open-market sale | 2,225 | $145.34 | $323K | Form 4 ↗ |
| Oct 1, 2026 | Grant or award | 12,517 | — | — | Form 4 ↗ |
| Aug 20, 2026 | Open-market sale | 3,396 | $143.79 | $488K | Form 4 ↗ |
| Aug 19, 2026 | Grant or award | 7,727 | — | — | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.